Summary of genetic, clinical, and biologic findings in patients with HPSII
. | Patient no. . | . | . | . | |||
---|---|---|---|---|---|---|---|
Characteristic . | P40* . | P42* . | P87† . | P04/05‡ . | |||
Genetic mutation | Del390-480,L580R | 390-410Del,L580R | R509XE,659X | R320X homozygote | |||
Age at report, y | 20 | 25 | 5 | 2 | |||
Clinical characteristic | |||||||
Albinism | + | + | + | + | |||
Nystagmus | + | + | + | + | |||
Facial dysmorphia | − | − | + | + | |||
Dysplastic acetabulae | + | + | ? | + | |||
Developmental delay | − | − | + | + | |||
Poor balance | + | + | ? | − | |||
Pulmonary fibrosis | + | + | + | ? | |||
Bleeding (moderate) | + | + | + | + | |||
Neutrophil count, μL | 200-832 | 320-1160 | 530-1635 | 0-992 | |||
Recurrent Infection | URI | URI | RSV, flu, rota, Pseudomonas | Strep, Staph, Klebs, Candida | |||
Hepatosplenomegaly | ? | ? | + | + | |||
Hemophagocytosis | + | ||||||
Biologic characteristic | |||||||
PLT aggregation | ↓ ADP, Coll | ↓ ADP, Coll | ↓ ADP, Coll, Epi | ↓ ADP, Coll, Epi | |||
PLT-dense bodies | Absent | Absent | Absent | Reduced, enlarged | |||
CD63 expression | ↑ Fibroblast | ↑ Fibroblast | ↑ Fibroblast | ↑ PLT, CTL§ | |||
Cytolytic activity | ? | ? | ? | ↓ CTL,§ NK |
. | Patient no. . | . | . | . | |||
---|---|---|---|---|---|---|---|
Characteristic . | P40* . | P42* . | P87† . | P04/05‡ . | |||
Genetic mutation | Del390-480,L580R | 390-410Del,L580R | R509XE,659X | R320X homozygote | |||
Age at report, y | 20 | 25 | 5 | 2 | |||
Clinical characteristic | |||||||
Albinism | + | + | + | + | |||
Nystagmus | + | + | + | + | |||
Facial dysmorphia | − | − | + | + | |||
Dysplastic acetabulae | + | + | ? | + | |||
Developmental delay | − | − | + | + | |||
Poor balance | + | + | ? | − | |||
Pulmonary fibrosis | + | + | + | ? | |||
Bleeding (moderate) | + | + | + | + | |||
Neutrophil count, μL | 200-832 | 320-1160 | 530-1635 | 0-992 | |||
Recurrent Infection | URI | URI | RSV, flu, rota, Pseudomonas | Strep, Staph, Klebs, Candida | |||
Hepatosplenomegaly | ? | ? | + | + | |||
Hemophagocytosis | + | ||||||
Biologic characteristic | |||||||
PLT aggregation | ↓ ADP, Coll | ↓ ADP, Coll | ↓ ADP, Coll, Epi | ↓ ADP, Coll, Epi | |||
PLT-dense bodies | Absent | Absent | Absent | Reduced, enlarged | |||
CD63 expression | ↑ Fibroblast | ↑ Fibroblast | ↑ Fibroblast | ↑ PLT, CTL§ | |||
Cytolytic activity | ? | ? | ? | ↓ CTL,§ NK |
+ indicates presence; −, absence; ?, unknown; URI, upper-respiratory infection; RSV, respiratory syncytial virus; rota, rotavirus infection; strep, streptococcal infection; staph, staphylococcal infection; Klebs, Klebsiella infection; Coll, collagen; Epi, epinephrine; and Plt, platelet.
Data for this patient are from Dell' Angelica et al14 and Shotelersuk et al.15
Data for this patient are from Huizing et al.16
Data for this patient are from this study.
These findings were also reported in CTLs obtained from a fifth patient with HPSII, for whom no further clinical details are available (Clark et al13 ).